TWO · Healthcare

TaiwanJ Pharmaceuticals Co., Ltd. (6549)

Biotechnology

TaiwanJ Pharmaceuticals Co., Ltd. (6549) is listed on TWO in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 6549

P/E ratio

25.00

TaiwanJ Pharmaceuticals Co., Ltd. (6549) — FAQ

What is 6549's P/E ratio?

The price-to-earnings (P/E) ratio for TaiwanJ Pharmaceuticals Co., Ltd. (6549) is 25.00 (data as of 2026-05-23).

Does TaiwanJ Pharmaceuticals Co., Ltd. pay a dividend?

Dividend yield is not available in the current snapshot for TaiwanJ Pharmaceuticals Co., Ltd. (6549). Check the MyAverix Finance app for the latest dividend data.

What sector is TaiwanJ Pharmaceuticals Co., Ltd. in?

TaiwanJ Pharmaceuticals Co., Ltd. (6549) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 6549 listed on?

6549 is listed on TWO.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)